NASDAQ
Entero Therapeutics, Inc. (ENTO) has a price/sales ratio of 207.82x as of Friday, May 22, 2026. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.